PharVision Advisers’s LegalZoom.com LZ Stock Holding History

PharVision Advisers’s Portfolio LZ Stock Details LZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,397	Closed	-$232K	–	416
2025 Q4	$232K	Buy	23,397 +11,457	+96%	+$114K	0.12%	435
2025 Q3	$124K	Buy	+11,940	New	+$119K	0.07%	598
2025 Q2	–	Sell	-15,662	Closed	-$135K	–	367
2025 Q1	$135K	Sell	15,662 -59,877	-79%	-$536K	0.19%	234
2024 Q4	$567K	Buy	+75,539	New	+$569K	0.48%	27

Other funds holding LZ

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMI

Technology Crossover Management IX Menlo Park, California $752M AUM 25.7% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's LZ Position: Q1 2026 in Review

PharVision Advisers sold out of LegalZoom.com (LZ) in Q1 2026, closing a stake of 23,397 shares — an estimated $232K sold.

PharVision Advisers first reported a position in LZ in Q4 2024 and held it in 4 quarters. The position peaked at $567K in Q4 2024. 237 funds tracked by Wall St. Rank hold LZ as of Q1 2026.

PharVision Advisers reported no remaining LegalZoom.com position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 23,397 LegalZoom.com shares in Q1 2026, an estimated $232K.
PharVision Advisers first reported a position in LegalZoom.com in Q4 2024 and held it in 4 quarters.
PharVision Advisers's LegalZoom.com position peaked at $567K in Q4 2024.
237 funds tracked by Wall St. Rank held LegalZoom.com as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.